Global Chemotherapy Market Insights Forecasts to 2033.

• The Global Chemotherapy Market Size was Valued at USD 8.6 Billion in 2023.
• The Market Size is Growing at a CAGR of 6.54% from 2023 to 2033.
• The Worldwide Chemotherapy Market Size is Expected to Reach USD 16.2 Billion by 2033.
• Europe is expected to Grow the fastest during the forecast period.

The Global Chemotherapy Market Size is Anticipated to Exceed USD 16.2 Billion by 2033, Growing at a CAGR of 6.54% from 2023 to 2033.  

Market Overview

Chemotherapy is the use of medicine or drugs for the treatment of cancer via inhibition of cancer cell proliferation and multiplication of tumors inside the body subsequently leading to the cure of cancer and its symptoms. Targeted and immune-based therapy is used for treating cancer. Combination or multitargeted therapy is the common and superior choice over single-agent therapy which is based upon principles of fraction kill and glodie-coldman hypothesis. Chemotherapy is also used with radiation therapy before surgery or curative intent for treating head, neck, lung, and anal cancer. The mechanism of action of chemotherapeutic drugs is based upon attacking dividing cancer cells, damaging genetic material, and sometimes blocking chemicals required for cell division. The drugs used in chemotherapy are alkylating agents, antimetabolites, anti-tumor antibiotics, topoisomerase inhibitors, mitotic inhibitors, plant alkaloids, corticosteroids, and miscellaneous antineoplastic to subsequently inhibit tumor growth within the cell and its environment. Chemotherapy may also lead to an attack on normal cells that leads to normal cell death resulting in hair loss which is the common side effect of cancer treatment. One or more chemotherapeutic agents, such as anti-cancer medications, are used in chemotherapy, a cancer treatment.     

Report Coverage

This research report categorizes the market for the global chemotherapy market based on various segments and regions forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the global chemotherapy market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the global chemotherapy market.

Driving Factors

The growing prevalence of cancer raises the healthcare demand for chemotherapy treatment which subsequently leads to the enhancement of the chemotherapy market. There are efforts taken by government organizations to support the chemotherapy market via conducting research and training on the cancer cause, diagnosis, and treatment. Further, rising healthcare cost for infrastructure and fund provided by pharmaceutical companies growing the market demand of chemotherapy. For instance, Pfizer purchased Array BioPharma in June 2019, intending to expand its oncology footprint and pipeline, starting with a melanoma combination medication that has been licensed and is currently testing for metastatic colorectal cancer. This is expected to accelerate the market. 

Restraining Factors

The high development costs associated with R&D of chemotherapeutic drugs and new cancer treatment restrain the market. Further, the requirement of expensive clinical trials for the approval of chemotherapeutic drug likely to raise the market. Stringent regulatory requirements for approval of drugs and patent expirations for cancer drug reduced the market share and revenue for original manufacturers. Furthermore, side-effects associated with chemotherapy drugs and occurrence of drug resistance likely to restrain the market.    

Market Segmentation

The Global Chemotherapy Market share is classified into drug class, indication, route of drug administration, and end-user.

• The alkylating agent segment is expected to hold the largest share of the global chemotherapy market during the forecast period.   

Based on the drug class, the global chemotherapy market is divided into mitotic inhibitors, alkylating agents, antimetabolites, topoisomerase inhibitors and antitumor antibiotic. Among these, the alkylating agent segment is expected to hold the largest share of the global chemotherapy market during the forecast period. The increasing rate of cancer cases globally and increased pipeline research expelling the market. Additionally, the rising healthcare cost for cancer treatment is likely to propel the chemotherapy market as alkylating agents are most widely used for chemotherapy. It is also commonly used in combination therapy.

• The leukemia segment is expected to grow at the fastest pace in the global chemotherapy market during the forecast period.    

Based on the indication, the global chemotherapy market is divided into breast cancer, lung cancer, colorectal cancer, prostate cancer, stomach cancer, lymphoma, leukemia and ovarian cancer. Among these, the leukemia segment is expected to grow at the fastest pace in the global chemotherapy market during the forecast period. The increasing cases of breast cancer raise the demand for chemotherapy. Leukemia accounted for approximately 2.5% of all new cancer incidence and 3.1% of cancer-related mortality.

• The oral segment is expected to grow at the greatest pace in the global chemotherapy market during the forecast period.

Based on the route of drug administration, the global chemotherapy market is divided into intravenous, oral, subcutaneous, intra-muscular, intravesicular, topical, intraperitoneal and intraventricular/intrathecal. Among these, the oral segment is expected to grow at the greatest pace in the global chemotherapy market during the forecast period. The oral category of chemotherapy is the largest contributor to dominating the chemotherapy market.  The pill, capsule, or liquid form of chemotherapeutic drugs is administered orally. As oral-administered drugs have greater efficacy than topically applied drugs thus market growth in oral segment is significant.

• The hospital & clinics segment is expected to grow at the greatest pace in the global chemotherapy market during the forecast period.

Based on the end-user, the global chemotherapy market is divided into specialty centers and hospitals & clinics. Among these, the hospitals & clinics segment is expected to grow at the greatest pace in the global chemotherapy market during the forecast period. The precise treatment provided by hospital care centers and the presence of healthcare-qualified persons is likely to enhance that market in the hospital and clinics segment. Cutting-edge medical equipment is showing the fastest growth rate in the chemotherapy market. The rising chronic illness among the growing geriatric population is also responsible for market growth in hospitals and clinics.

Regional Segment Analysis of the Global Chemotherapy Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

North America is anticipated to hold the largest share of the global chemotherapy market over the predicted timeframe.

North America is anticipated to hold the largest share of the global chemotherapy market over the predicted timeframe. The presence of manufacturing companies and increased healthcare spending expelling the market in the region. Further, the accessibility of medical facilities and cutting-edge technology for the treatment of cancer raise market growth. It was estimated there were about 490,875 leukemia patients in the United States in 2020. The market in North America is anticipated to grow as a result of the high concentration of major companies, rising FDA approvals, strategic alliances, and significant investments in R&D.

Europe is expected to grow at the fastest pace in the global chemotherapy market during the forecast period. According to data from 2021 provided by the International Agency for the Research on Cancer, there were 4.79 million cancer cases in the European region in 2020, and that number is projected to rise to 6.07 million by 2040. The ease of regulatory approvals for novel drugs and rising R&D spending due to the rising prevalence of cancer are expected to influence the market in the region. Germany has the largest market share and the UK has the fastest growing market in the European region.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the global chemotherapy along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Pfizer Inc.
• Sanofi SA
• Johnson & Johnson Services Inc
• GlaxoSmithKline Plc.
• Novartis AG
• Eli Lilly & Company
• Merck & Co.
• Teva Pharmaceuticals
• Celgene Corporation
• Bayer AG
• Bristol-Myers Squibb
• Boehringer Ingelheim
• Takeda Pharmaceutical Company Limited
• Schering-Plough
• Chemo Espana SL
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent Developments

• In November 2022, AstraZeneca aims to redefine breast cancer care with new data across the treatment spectrum at SABCS 2022.

• In May 2022, Gland Pharma launched the generic cancer treatment drug Bortezomib for Injection in the US market.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the Global Chemotherapy Market based on the below-mentioned segments: 

Global Chemotherapy Market, By Drug Class

• Mitotic Inhibitors
• Alkylating Agents
• Antimetabolites
• Topoisomerase Inhibitors
• Antitumor Antibiotic

Global Chemotherapy Market, By Indication

• Breast Cancer
• Lung Cancer
• Colorectal Cancer
• Prostate Cancer
• Stomach Cancer
• Lymphoma
• Leukemia
• Ovarian Cancer

Global Chemotherapy Market, By Route of Drug Administration

• Intravenous
• Oral
• Subcutaneous
• Intra-Muscular
• Intravesicular
• Topical
• Intraperitoneal
• Intraventricular/Intrathecal

Global Chemotherapy Market, By End-User

• Specialty Centers
• Hospitals & Clinics

Global Chemotherapy Market, By Region

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • Uk
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa